2 pending office actions
| App # | Title | Examiner | Art Unit | Status | Filed |
|---|---|---|---|---|---|
| 18265915 | EGANELISIB FOR USE IN THE TREATMENT OF PD-L1 NEGATIVE CANCER | OTTON, ALICIA L | 1699 | Non-Final OA | Jun 07, 2023 |
| 18072314 | HETEROCYCLIC COMPOUNDS AND USES THEREOF | WHITE, DAWANNA SHAR-DAY | 1627 | Non-Final OA | Nov 30, 2022 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial